Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Taki Galanis"'
Publikováno v:
Current Therapeutic Research, Vol 76, Iss C, Pp 76-83 (2014)
Background: Several novel oral anticoagulants have been studied for the prevention and treatment of venous thromboembolism (VTE) in different patient populations. Clinicians will increasingly encounter scenarios in which they must choose among these
Externí odkaz:
https://doaj.org/article/b2f6592d8a4540a4ba3858706d7f32ff
Autor:
Thomas J. O’Malley, Martín Mellado, Geno J. Merli, Vakhtang Tchantchaleishvili, Gregary D. Marhefka, Nicholas D. D’Antonio, Frances Mae West, Matthew P. Weber, Jae Hwan Choi, Bharat Awsare, Elizabeth J. Maynes, Carin F. Gonsalves, Taki Galanis
Publikováno v:
The Annals of Thoracic Surgery. 110:1072-1080
Background Acute pulmonary embolism (PE) is associated with significant mortality. Surgical embolectomy is a viable treatment option; however, it remains controversial as a result of variable outcomes. This review investigates patient outcomes after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c94a42d3034db4db97a2789a0d5dfd8a
https://doi.org/10.1016/j.athoracsur.2020.01.075
https://doi.org/10.1016/j.athoracsur.2020.01.075
Autor:
Daniel Z. Givner, Kapila Kommareddy, Jeontaik Kwon, Paul J. DiMuzio, Dawn M. Salvatore, Taki Galanis, Geno Merli, Luis Eraso, Michael J. Nooromid, Babak Abai
Publikováno v:
Journal of Vascular Surgery. 75:e228-e229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b11f239b90e8b37b4477324c469a4693
https://doi.org/10.1016/j.jvs.2022.03.477
https://doi.org/10.1016/j.jvs.2022.03.477
Autor:
Luis H. Eraso, Eugene R. Viscusi, Geno J. Merli, Jerald Z. Gong, Taki Galanis, Edwin Lam, Lynda Thomson, Geoffrey Ouma, Walter K. Kraft
Publikováno v:
Vascular medicine (London, England). 27(3)
Background: Apixaban pharmacokinetic properties and some clinical reports suggest cessation 48 hours prior to surgery is safe, but this has not been demonstrated in a naturalistic setting. We sought to measure the residual apixaban exposure in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45738b5b52df38e9125f7bbb00433c32
https://pubmed.ncbi.nlm.nih.gov/34809507
https://pubmed.ncbi.nlm.nih.gov/34809507
Publikováno v:
Hospital Practice. 47:192-195
Pylephlebitis is a rare condition that is characterized by an infected thrombus of the portal vein system and was traditionally associated with a high mortality rate prior to the introduction of antibiotics. This report details a 77-year-old Chinese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cced06d25c334b404055a9500c5fe3a
https://doi.org/10.1080/21548331.2019.1670476
https://doi.org/10.1080/21548331.2019.1670476
Autor:
Taki Galanis, Vakhtang Tchantchaleishvili, Martín Mellado, Nicholas D. D’Antonio, Carin F. Gonsalves, Bharat Awsare, Chelsey T. Wood, Geno J. Merli, Frances Mae West, Thomas J. O’Malley, Jae Hwan Choi, Elizabeth J. Maynes, Gregary D. Marhefka
Publikováno v:
Resuscitation. 146
Background Massive pulmonary embolism (PE) can cause hemodynamic instability leading to high mortality. Extracorporeal life support (ECLS) has been increasingly used as a bridge to definitive therapy. This systematic review investigates the outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6109b52a0d94a3b1baeed52584a9038e
https://pubmed.ncbi.nlm.nih.gov/31790756
https://pubmed.ncbi.nlm.nih.gov/31790756
Autor:
John Spandorfer, Taki Galanis
Publikováno v:
Annals of Internal Medicine. 162:ITC1-ITC16
This issue provides a clinical overview of deep venous thrombosis, focusing on prevention, diagnosis, treatment, and patient information. The content of In the Clinic is drawn from the clinical information and education resources of the American Coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97c0f177d4895d8fda261dfcf2ae0e1c
https://doi.org/10.7326/aitc201505050
https://doi.org/10.7326/aitc201505050
Autor:
Taki Galanis, Geno J. Merli
Publikováno v:
Cardiology Clinics. 33:49-57
Venous thromboembolism (VTE) is a potentially fatal condition and includes deep vein thrombosis and pulmonary embolism. The novel oral anticoagulants, which include the direct thrombin and factor Xa inhibitors, have been shown to be safe and effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65bf2bee4a082fc6ef258a6bc4d6dfa8
https://doi.org/10.1016/j.ccl.2014.09.007
https://doi.org/10.1016/j.ccl.2014.09.007
Publikováno v:
Current Therapeutic Research, Clinical and Experimental
Current Therapeutic Research, Vol 76, Iss C, Pp 76-83 (2014)
Current Therapeutic Research, Vol 76, Iss C, Pp 76-83 (2014)
Background: Several novel oral anticoagulants have been studied for the prevention and treatment of venous thromboembolism (VTE) in different patient populations. Clinicians will increasingly encounter scenarios in which they must choose among these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c56593db86b12b618512473440c7b1cf
https://doi.org/10.1016/j.curtheres.2014.06.002
https://doi.org/10.1016/j.curtheres.2014.06.002
Autor:
Suzanne Adams, Luis H. Eraso, Eugene R. Viscusi, Douglas F. Stickle, Walter K. Kraft, Jerald Z. Gong, Taki Galanis, Lynda Thomson, Geoffrey Ouma, Geno J. Merli, Edwin Lam
Publikováno v:
Journal of the American College of Cardiology. 73:1942
The regulatory labeling for apixaban outlines discontinuing apixaban 24 to 48 hours prior to surgery depending on the bleeding risk. This is based upon the known pharmacokinetics of the drug derived from controlled populations. Data evaluating these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11bc0117f461b5389504fb5d91106858
https://doi.org/10.1016/s0735-1097(19)32548-3
https://doi.org/10.1016/s0735-1097(19)32548-3